Global Single Cell Analysis Market is anticipated to reach USD 5.9 billion in the forecast period. Single-cell analysis is the study of transcriptomics, genomics, metabolomics and proteomics at the single cell level. The analysis provides the type of examination which is helpful in various segments and it has been supported by the constant technological updates in research implements.

Factors, such as increasing focus on personalized medicine, technological developments in single-cell analysis products, increasing research and development in the single cell analysis field, rapid progression in the healthcare segment across the globe and partnership and collaboration among key players to favor market development are likely to drive the single-cell analysis industry in forthcoming period.

On the other hand, high cost of single-cell analysis products and lack of awareness are anticipated to hinder the market growth of single cell analysis in the future. However, growth in stem cell research is likely to create lucrative opportunities for the market. Single cell analysis market is anticipated to expand at a significant CAGR in the upcoming period as the scope, product types, and its applications are increasing across the globe.

Request a Free Sample Copy of Single Cell Analysis Market Report @  https://www.millioninsights.com/industry-reports/single-cell-analysis-market/request-sample

Single cell analysis industry is segmented by product type, types of cell, technique, application, end user and geography. Based on product segmentation, the single cell market comprises Consumable, and Instruments. The “Consumable” segment accounted for a prominent share in the market. It is likely to witness substantial growth in the years to come. The key factors that could be attributed to the growth of the market include existing players accepting numerous policies to boost sales and continuous demand from end users.

Based on types of cell, the single-cell analysis market could span Animal, Human, and Microbial Cells. The market could be explored based on technique as Polymerase Chain Reaction, Mass Spectroscopy, and Others. The key applications that could be explored in the single cell analysis industry include Diagnostic and Research Applications. Single cell analysis market could be explored by the end user as Biotechnology and Biopharmaceutical Companies, Academic & Research Institutes, and Others.

North America is a leading region in the market. It is likely to maintain a dominance in the forecast period owing to factors, such as the establishment of new biopharmaceutical and biotechnology products in the region. Furthermore, acceptance of gene-based analysis methods by these companies and research laboratories is increasing the regional market growth.

In addition, North America is followed by the Asia-Pacific region owing to several government initiatives undertaken to progress healthcare infrastructure, accessibility of skilled specialists to work advanced analytical instruments, and increasing healthcare spending.

Key players operating in the single cell analysis industry include Abcam Plc., 10X Genomics, Agilent Technologies, Becton, Fluxion Biosciences, Bio-Rad Laboratories, Inc., Dickinson and Company, Illumina, Danaher Corporation, Bruker, GE Healthcare, Fluidigm Corporation, and Bio-Techne Corporation, among others. The leading companies are taking up partnerships, mergers and acquisitions, and joint ventures in order to boost the inorganic growth of the industry.

The report “Single Cell Analysis Market Size & Forecast Report, 2014 - 2025” is available now at https://www.millioninsights.com/industry-reports/single-cell-analysis-market

Market Segment:

Single Cell Analysis Product Type Outlook (Revenue, USD Million, 2014 - 2025)
• Consumables
• Reagents
• Assay Kits
• Other Consumables
• Instruments
• Manual Instruments
• Microscopes
• Haemocytometers
• Automated Instruments
• Flowcytometers
• Next Generation Sequencing
• PCR Systems
• High-content Screening System
• Cell Microarrays
• Automated Cell Counters

Single Cell Analysis Application Type Outlook (Revenue, USD Million, 2014 - 2025)
• Cancer
• Immunology
• Neurology
• Stem Cell
• Non-invasive Prenatal Diagnosis
• In-vitro Fertilization

Single Cell Analysis Regional Outlook (Revenue, USD Million, 2014 - 2025)
• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• Asia Pacific
• China
• India
• Latin America
• Mexico
• Brazil
• Middle East & Africa
• South Africa

To read more reports of this category, Visit our blog:   https://healthandpharmamarketers.tumblr.com 

Global Single Cell Analysis Market is anticipated to reach USD 5.9 billion in the forecast period. Single-cell analysis is the study of transcriptomics, genomics, metabolomics and proteomics at the single cell level. The analysis provides the type of examination which is helpful in various segments and it has been supported by the constant technological updates in research implements.

Free Exclusive Sample of this Report @ https://bit.ly/3wbJxN6

Factors, such as increasing focus on personalized medicine, technological developments in single-cell analysis products, increasing research and development in the single cell analysis field, rapid progression in the healthcare segment across the globe and partnership and collaboration among key players to favor market development are likely to drive the single-cell analysis industry in forthcoming period.

On the other hand, high cost of single-cell analysis products and lack of awareness are anticipated to hinder the market growth of single cell analysis in the future. However, growth in stem cell research is likely to create lucrative opportunities for the market. Single cell analysis market is anticipated to expand at a significant CAGR in the upcoming period as the scope, product types, and its applications are increasing across the globe.

Single cell analysis industry is segmented by product type, types of cell, technique, application, end user and geography. Based on product segmentation, the single cell market comprises Consumable, and Instruments. The “Consumable” segment accounted for a prominent share in the market. It is likely to witness substantial growth in the years to come. The key factors that could be attributed to the growth of the market include existing players accepting numerous policies to boost sales and continuous demand from end users.

Based on types of cell, the single-cell analysis market could span Animal, Human, and Microbial Cells. The market could be explored based on technique as Polymerase Chain Reaction, Mass Spectroscopy, and Others. The key applications that could be explored in the single cell analysis industry include Diagnostic and Research Applications. Single cell analysis market could be explored by the end user as Biotechnology and Biopharmaceutical Companies, Academic & Research Institutes, and Others.

North America is a leading region in the market. It is likely to maintain a dominance in the forecast period owing to factors, such as the establishment of new biopharmaceutical and biotechnology products in the region. Furthermore, acceptance of gene-based analysis methods by these companies and research laboratories is increasing the regional market growth.

In addition, North America is followed by the Asia-Pacific region owing to several government initiatives undertaken to progress healthcare infrastructure, accessibility of skilled specialists to work advanced analytical instruments, and increasing healthcare spending.

Key players operating in the single cell analysis industry include Abcam Plc., 10X Genomics, Agilent Technologies, Becton, Fluxion Biosciences, Bio-Rad Laboratories, Inc., Dickinson and Company, Illumina, Danaher Corporation, Bruker, GE Healthcare, Fluidigm Corporation, and Bio-Techne Corporation, among others. The leading companies are taking up partnerships, mergers and acquisitions, and joint ventures in order to boost the inorganic growth of the industry.

Access Full Report With TOC @ https://bit.ly/3pzHBLS

 Market Segment:

Single Cell Analysis Product Type Outlook (Revenue, USD Million, 2014 - 2025)
    • Consumables
        • Reagents
        • Assay Kits
        • Other Consumables
    • Instruments
        • Manual Instruments
        • Microscopes
        • Haemocytometers
        • Automated Instruments
        • Flowcytometers
        • Next Generation Sequencing
        • PCR Systems
        • High-content Screening System
        • Cell Microarrays
        • Automated Cell Counters

Get in touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.

Contact Person:

Ryan Manuel

Research Support Specialist, USA

Email:ryan@millioninsights.com

The growth in this market is driven by technological advancements in single-cell analysis products, increasing government funding for cell-based research, growing biotechnology and bio-pharmaceutical industries, wide applications of single-cell analysis in cancer research, growing focus on personalized medicine, and the increasing incidence and prevalence of chronic and infectious diseases, single cell isolation market.

How the Market Growth looks like and Industry Segmentation?

The Single-cell Analysis Market is projected to reach USD 5.6 billion by 2025, at a CAGR of 17.8% during the forecast period.

The consumables segment accounted for the largest share of the single-cell analysis market, by product, in 2018

Based on product, the market is segmented into consumables (beads, microplates, reagents, assay kits, and other consumables) and instruments (flow cytometers, NGS systems, PCR instruments, spectrophotometers, microscopes, cell counters, HCS systems, microarrays, and other instruments). The consumables segment accounted for the largest market share in 2018. The large share of this segment can be attributed to the frequent purchase of these products as compared to instruments, which are considered as a one-time investment, and their wide applications in research and genetic exploration, exosome analysis, and isolation of RNA and DNA.

NGS is the fastest-growing segment of the single-cell analysis market, by technique

Based on technique, the market is segmented into flow cytometry, NGS, PCR, microscopy, mass spectrometry, single-cell rna sequencing and other techniques. The NGS segment is projected to register the highest growth rate of 20.0% during the forecast period. The high growth of the NGS segment is driven by the increasing application of single-cell analysis products in drug discovery for cancer and other chronic diseases.

Browse 225 market data Tables and 50 Figures spread through 252 Pages and in-depth TOC – Request Research Sample Pages: 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=171955254

 

 

Recent Developments:

• In November 2019, QIAGEN launched QIAseq Multimodal Panels, which have been developed for consolidated targeted DNA and RNA enrichment and analyses. These panels save time and conserve samples that are of limited availability.
• In July 2019, QIAGEN partnered with Illumina with the aim to broaden the availability and use of NGS-based in vitro diagnostic (IVD) kits.
• In June 2019, Beckman Coulter acquired Cytobank, Inc. (US) to integrate Cytobank’s software into Beckman Coulter’s product portfolio to provide innovative solutions to customers.
• In July 2018, 10x Genomics partnered with BioLegend to develop ready-to-use solutions for the simultaneous measurement of highly multiplexed proteins and unbiased gene expression from single cells.
• In March 2018, Danaher Corporation acquired Integrated DNA Technologies. This acquisition aimed at expanding Danaher’s presence in the highly attractive genomics market.

Geographical Regions Mapped in Report:

The global single-cell analysis market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2018, North America accounted for the largest share of the market. The growth in this market can be attributed to the increasing drug development activities in the pharmaceutical and biotechnology industries, rising prevalence of chronic and infectious diseases, and an increase in stem cell research activities.

Download PDF Brochure: 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=171955254

Prominent players in the single-cell analysis market include Becton, Dickinson and Company (US), Danaher Corporation (US), Merck Millipore (US), QIAGEN (Netherlands), Thermo Fisher Scientific (US), General Electric Company (US), 10x Genomics (US), Promega Corporation (US), Illumina (US), Bio-Rad Laboratories (US), Fluidigm Corporation (US), Agilent Technologies (US), NanoString Technologies (US), Tecan Group (Switzerland), Sartorius AG (Germany), Luminex Corporation (US), Takara Bio (Japan), Fluxion Biosciences (US), Menarini Silicon Biosystems (Italy), and LumaCyte (US).